News

A report from KLAS Research ranks sheds light on these popular tools and how vendors are missing the mark.

Executives speculate on what’s next following the remote patient monitoring CMS rule.

Promising new technology/biotechnology is on the horizon for migraine sufferers, according to a headache expert from Cleveland Clinic.

A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.

FDA recently approved a new treatment for 2 rare types of non-Hodgkin lymphomas, as well as a new drug to treat hereditary angiodema and 1 for Fabry disease. Here are the top three new drugs to treat rare diseases.

Cutting-edge technologies, as well as upgrades to existing technology tools, will improve diabetes care. Here's how.

While FDA approved the first drug containing cannibidiol (CBD), it is cracking down on certain other CBD products marketed as supplements.

Cancer is one of the top deadliest diseases in the world and can be difficult to treat. We want to hear from you about your current challenges and what you think about future prospects in cancer therapy.

Combat stress, PTSD, depression, anxiety, and substance use disorder are genuine, serious and treatable medical conditions. Here’s how one operator is tackling all of them.

To help build a stronger community support system and strategy around mental health, here are three tips for managed care organizations.

A HealthMine survey has interesting results about Medicare Advantage members’ knowledge about virtual care. Here’s six ways to reach them.

Reasons organizations have traditionally had for not sharing data with each other are breaking down, opening a new type of conversation between payers and providers. Here’s how.

Increasingly, healthcare organizations are relying on information technology (IT) solutions to increase the reach-and efficacy-of healthcare. Here’s how technology can help mental health, too.

Suicide rates are rising-but healthcare organizations can help facilitate their suicide prevention efforts by relying on the right care coordination teams.

Here are four other things that MCOs should know about a first-of-its kind targeted RNA-based therapy to treat a rare disease.

Measuring success in the value-based care era requires establishing a baseline and implementing new technology tools.

Ready to conquer your email inbox? Here are tips for healthcare executives.

Medical malpractice companies partner to provide a detailed analysis of breast cancer medical malpractice claims. The findings may surprise you.

FDA clears first-of-its-kind gene therapy for rare disease.

While FDA approved the first generic version of epinephrine (EpiPen and EpiPen Jr, Mylan), the new product is not yet on the market.

The importance of the retail setting as a hub for health engagement is increasing. Here’s three things you need to know about it.

A new study may offer healthcare organizations a new way to close gaps in care while simultaneously engaging the patient as a partner in care.

Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.

You can’t make every patient satisfied every time, but it’s worth a shot. Here are 10 simple strategies for providers to consider.

New research from Prophet shares five key shifts healthcare organizations can make in the move toward consumer-centricity.

A new survey has shocking results about consumer knowledge of health insurance.

Pharmaceutical industry observers are concerned about some of the drugs that were slashed from Express Scripts’ 2019 National Preferred Formulary.